General MedicationsORALGeneric

VERSED

MIDAZOLAM HYDROCHLORIDE

Standard Dose

EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: PRIORITY Marketing status: Discontinued

Summary

Approval overview VERSED is listed in Drugs@FDA under application 020942 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SYRUP;ORAL - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROCHE Submission history Latest submission status date: 2001-05-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview VERSED is listed in Drugs@FDA under application 020942 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SYRUP;ORAL - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROCHE Submission history Latest submission status date: 2001-05-17 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: PRIORITY

Interaction Notes

No interaction notes stored yet.